No coincidence that Mohammad Afshar (3), Coralie Williams (3), Frederic Parmentier (3) and Martin Kindermans (3) all of Ariana are mentioned, nor that Missling 15th Oct could say the PDD trial was stat sig and talk to SIGMAR1 subgroups or when questioned by the analyst said paraphrased "I won't go into that now".
To me this all says Anavex have had the data for some time and have done a great deal of analysis already. Enough to have secured a late breaking slot at CTAD for Parkison's Dementia based on the data having relevance for the ongpong P2b/3 Alzheimer's trial.
News 
Market Data 
Discover 
